Answers are grounded in this paper and cite their sources.
RNA binding protein (RBP) controls multiple aspects of RNA metabolism and plays crucial roles in many physiopathological contexts, including cancer. We recently identified an RBP HNRNPL as a novel prostate cancer dependency via regulation of RNA splicing, suggesting the potential to target RBP or RBP-RNA interaction to treat cancer.
No takes yet. Share an insight, caveat, or question.
Fei Teng (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: